repurposed dasatinib (IGIA Pharmaceutical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namerepurposed dasatinib (IGIA Pharmaceutical)
Drug Alias Namedasatinib monolauryl sulfateIG-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsNoonan Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIGIA Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIGIA Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNoonan Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A